2017
DOI: 10.1093/ecco-jcc/jjx002.599
|View full text |Cite
|
Sign up to set email alerts
|

P474 An enzyme-linked immunosorbent assay for therapeutic drug monitoring of vedolizumab

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Different types of assays are also popular to quantify the presence of drug traces including antibiotics. Among them, enzyme-linked immunosorbent assays, fluorescence immunoassays, 19 and radioimmune assays were successfully applied to detect the presence of drugs like neomycin, 20 thiamine, 21 and other drugs like infliximab, 22 vedolizumab, 23 benzoylecgonine, 24 etc. Although cross-reactions may impair the precision and detection accuracy of such assays, a high detection threshold stands as a barrier and insists to find out other better methods.…”
Section: Introductionmentioning
confidence: 99%
“…Different types of assays are also popular to quantify the presence of drug traces including antibiotics. Among them, enzyme-linked immunosorbent assays, fluorescence immunoassays, 19 and radioimmune assays were successfully applied to detect the presence of drugs like neomycin, 20 thiamine, 21 and other drugs like infliximab, 22 vedolizumab, 23 benzoylecgonine, 24 etc. Although cross-reactions may impair the precision and detection accuracy of such assays, a high detection threshold stands as a barrier and insists to find out other better methods.…”
Section: Introductionmentioning
confidence: 99%